Loading…
Improving Access to Transfusion Care for Hospice Patients Act of 2021
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,357 other S bills in the 117th — cohort avg 38d
Improving Access to Transfusion Care for Hospice Patients Act of 2021 This bill requires the Center for Medicare and Medicaid Innovation (CMMI) to test a model under which blood transfusions furnished to an individual receiving hospice care are paid separately from the hospice all-inclusive per diem payment under Medicare. The CMMI must evaluate the model by comparing patients participating in the model with those outside of the model in relation to specified metrics, such as hospital utilization and days of hospice care before the end of life.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (5)
2022 · fourth_quarter · Medicare/Medicaid
Read twice and referred to the Committee on Finance.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Coverage of blood transfusions under Medicare Hospice Benefit Improving Access to Transfusion Care for Hospice Patients Act of 2021 (S. 2566) Issues related to CAR-T/cellular and gene therapies Implementation of the Medicare Access and CHIP Reauthorization Act pf 2015 (P.L. 114-10) Implementation of the Patient Protection and Affordable Care Act (P.L. 111-148) CMS national coverage determinations Medicaid coverage for sickle cell disease Issues impacting opioid access/use for patients with hematologic disease and disorders Issues related to implementation of Coronavirus Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136) Issues related to health equity/disproportionate impact of COVID-19 on minority populations Issues related to telemedicine/telehealth COVID-19 vaccination policies/prioritization Resident Physician Shortage Reduction Act (H.R. 2256/S. 834) Healthcare Workforce Resilience Act (H.R. 2255/S. 1024) Cures 2.0 Act (H.R. 6000) Sickle cell disease/trait issues Sickle Cell Disease Comprehensive Care Act (H.R. 6216 / S.3389) Prior authorization Improving Seniors Timely Access to Care Act (H.R. 3173/S. 3018) Advancing Telehealth Beyond COVID Act (H.R. 4040) Supporting Medicare Providers Act (H.R. 8800) FY2023 Consolidated Appropriations Act (H.R. 2617)
Client expense: $30,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · fourth_quarter · Medicare/Medicaid
S.3389/ H.R.6216 - Sickle Cell Disease Comprehensive Care Act H.R. 2617 - Consolidated Appropriations Act of 2023 - Medicare provisions to eliminate cuts in physician payment and Medicaid provisions related to inclusion of S.3389/HR 6216. Making permanent Medicare telehealth expansions allowed during Public Health Emergency Legislation to eliminate CMS planned reductions to Medicare Physician Fee Schedule Conversion Factor and other payment reductions in Medicare proposed for 2022 The Improving Access to Transfusion Care for Hospice Patients Act of 2021 (S. 2566) Need for expert panel to advise CMS on improving values for evaluation and management services National Coverage Determination on myelodysplastic syndromes (MDS) Request for a Center for Medicare and Medicaid Innovation demonstration program for sickle cell disease
Client expense: Not reported · Firm income: $45,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Medicare/Medicaid
S.3389/ H.R.6216 - Sickle Cell Disease Comprehensive Care Act Making permanent Medicare telehealth expansions allowed during Public Health Emergency Legislation to eliminate CMS planned reductions to Medicare Physician Fee Schedule Conversion Factor and other payment reductions in Medicare proposed for 2022 The Improving Access to Transfusion Care for Hospice Patients Act of 2021 (S. 2566) Need for expert panel to advise CMS on improving values for evaluation and management services Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long-Term Care Hospital Prospective Payment System and Proposed Policy Changes and Fiscal Year 2023 Rates Comments in response to CY2023 Medicare Physician Fee Schedule (CMS-1770-P) National Coverage Determination on myelodysplastic syndromes (MDS) Issues related to Medicare coverage of childhood vaccines for patients post-stem cell transplant
Client expense: Not reported · Firm income: $45,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Medicare/Medicaid
Coverage of blood transfusions under Medicare Hospice Benefit Improving Access to Transfusion Care for Hospice Patients Act of 2021 (S. 2566) Issues related to CAR-T/cellular and gene therapies Implementation of the Medicare Access and CHIP Reauthorization Act pf 2015 (P.L. 114-10) Implementation of the Patient Protection and Affordable Care Act (P.L. 111-148) CMS national coverage determinations Medicaid coverage for sickle cell disease Issues impacting opioid access/use for patients with hematologic disease and disorders Issues related to implementation of Coronavirus Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136) Issues related to health equity/disproportionate impact of COVID-19 on minority populations Issues related to telemedicine/telehealth COVID-19 vaccination policies/prioritization Resident Physician Shortage Reduction Act (H.R. 2256/S. 834) Healthcare Workforce Resilience Act (H.R. 2255/S. 1024) Cures 2.0 Act (H.R. 6000) Sickle cell disease/trait issues Sickle Cell Disease Comprehensive Care Act (H.R. 6216 / S.3389) Prior authorization Improving Seniors Timely Access to Care Act (H.R. 3173/S. 3018) Advancing Telehealth Beyond COVID Act (H.R. 4040)
Client expense: $30,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · second_quarter · Medicare/Medicaid
S.3389/ H.R.6216 - Sickle Cell Disease Comprehensive Care Act Making permanent Medicare telehealth expansions allowed during Public Health Emergency Legislation to eliminate CMS planned reductions to Medicare Physician Fee Schedule Conversion Factor and other payment reductions in Medicare proposed for 2022 The Improving Access to Transfusion Care for Hospice Patients Act of 2021 (S. 2566) Need for expert panel to advise CMS on improving values for evaluation and management services National Coverage Determination on myelodysplastic syndromes (MDS) Issues related to Medicare coverage of childhood vaccines for patients post-stem cell transplant
Client expense: Not reported · Firm income: $45,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Medicare/Medicaid
Coverage of blood transfusions under Medicare Hospice Benefit Improving Access to Transfusion Care for Hospice Patients Act of 2021 (S. 2566) Issues related to CAR-T/cellular and gene therapies Implementation of the Medicare Access and CHIP Reauthorization Act pf 2015 (P.L. 114-10) Implementation of the Patient Protection and Affordable Care Act (P.L. 111-148) CMS national coverage determinations Medicaid coverage for sickle cell disease Issues impacting opioid access/use for patients with hematologic disease and disorders Issues related to implementation of Coronavirus Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136) Issues related to health equity/disproportionate impact of COVID-19 on minority populations Issues related to telemedicine/telehealth COVID-19 vaccination policies/prioritization Resident Physician Shortage Reduction Act (H.R. 2256/S. 834) Healthcare Workforce Resilience Act (H.R. 2255/S. 1024) Cures 2.0 Act (H.R. 6000) Sickle cell disease/trait issues Sickle Cell Disease Comprehensive Care Act (H.R. 6216 / S.3389) Prior authorization Improving Seniors Timely Access to Care Act (H.R. 3173/S. 3018)
Client expense: $30,000 · Firm income: Not reported
2022 · second_quarter · Medicare/Medicaid
Medicare home health payment policy. Oppose home health and hospice payment cuts and co-pays. Home health rural add-on payment adjustment. Home Health Review Choice Demonstration Program. Hospice payment policy. CMMI VBID Medicare Advantage Carve-in proposal. H.R. 2898/S. 1399, Homecare for Seniors Act. Medicaid payment and eligibility policy. Medicaid Money Follows the Person program. Medicaid protections against spousal impoverishments. Administration for Community Living falls prevention program. H.R. 3371/S. 1309, Home Health Emergency Access to Telehealth Act. Hospice Face to Face Telehealth recertification. Patient Choice and Quality Care Act (draft legislation). Federal response to coronavirus pandemic, including: regulatory relief, PPE, testing, telehealth, Medicaid reimbursement, and homebound status. S. 2214, PROTECTS Act. Medicaid HCBS FMAP increase. HCBS Access Act (draft legislation). Additional funding for Provider Relief Fund. COVID-19 vaccine funding, administration, and distribution to the homebound. Increased minimum wage legislative proposals. H.R. 2903/S. 1512, CONNECT for Health Act of 2021. H.R. 3321/S. 1670, Credit for Caring Act of 2021. H.R. 3689/S. 234, Americans Giving Care to Elders (AGE) Act of 2021. COVID-19 Public Health Emergency/testing of hospice patients. H.R. 2565, Expanding Access to Palliative Care Act. H.R. 5514/S. 2562, Choose Home Care Act of 2021. H.R. 5376, Build Back Better Act. H.R. 4131/S.2210, Better Care Better Jobs Act. S. 2566, Improving Access to Transfusion Care for Hospice Patients Act of 2021. Draft legislation to remove advance care planning co-payments. Health information technology funding and standards for long-term post-acuter care providers. COVID-19 vaccine mandate. Palliative dialysis payment policy in Medicare hospice. H.R. 6698, Stop Unfair Medicaid Recoveries Act of 2022. H.R. 7053/S. 3792, Hospital Inpatient Services Modernization Act. Medicare Sequestration Moratoria. Hospice concurrent care policy. Community-based palliative care in CMMI alternative payment model demonstrations. H.R. 3173/S. 3018, Improving Seniors' Timely Access to Care Act.
2022 · first_quarter · Medicare/Medicaid
S.3389/ H.R.6216 - Sickle Cell Disease Comprehensive Care Act Making permanent Medicare telehealth expansions allowed during Public Health Emergency Legislation to eliminate CMS planned reductions to Medicare Physician Fee Schedule Conversion Factor and other payment reductions in Medicare proposed for 2022 The Improving Access to Transfusion Care for Hospice Patients Act of 2021 (S. 2566) Need for expert panel to advise CMS on improving values for evaluation and management services National Coverage Determination on myelodysplastic syndromes (MDS) The Sickle Cell Care Expansion Act (H.R. 7177)
Client expense: Not reported · Firm income: $45,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Medicare/Medicaid
Medicare home health payment policy. Oppose home health and hospice payment cuts and co-pays. Home health rural add-on payment adjustment. Home Health Review Choice Demonstration Program. Hospice payment policy. CMMI VBID Medicare Advantage Carve-in proposal. Palliative Care and Hospice Education and Training Act (draft legislation). H.R. 2898/S. 1399, Homecare for Seniors Act. Medicaid payment and eligibility policy. Medicaid Money Follows the Person program. Medicaid protections against spousal impoverishments. Administration for Community Living falls prevention program. H.R. 3371/S. 1309, Home Health Emergency Access to Telehealth Act. Hospice Face to Face Telehealth recertification. Patient Choice and Quality Care Act (draft legislation). Federal response to coronavirus pandemic, including: regulatory relief, PPE, testing, telehealth, Medicaid reimbursement, and homebound status. S. 2214, PROTECTS Act. Medicaid HCBS FMAP increase. HCBS Access Act (draft legislation). Additional funding for Provider Relief Fund. COVID-19 vaccine funding, administration, and distribution to the homebound. Increased minimum wage legislative proposals. H.R. 2903/S. 1512, CONNECT for Health Act of 2021. H.R. 3321/S. 1670, Credit for Caring Act of 2021. H.R. 3689/S. 234, Americans Giving Care to Elders (AGE) Act of 2021. COVID-19 Public Health Emergency/testing of hospice patients. H.R. 2565, Expanding Access to Palliative Care Act. H.R. 5514/S. 2562, Choose Home Care Act of 2021. H.R. 5376, Build Back Better Act. H.R. 4131/S.2210, Better Care Better Jobs Act. S. 2566, Improving Access to Transfusion Care for Hospice Patients Act of 2021. Draft legislation addressing Medicare Advantage coverage at end of life. Health information technology funding and standards for long-term post-acuter care providers. COVID-19 vaccine mandate. Palliative dialysis payment policy in Medicare hospice. H.R. 4952, ChiPACC Act of 2021. H.R. 6000, Cures 2.0 Act. Long-term care health information technology modernization proposals. H.R. 6698, Stop Unfair Medicaid Recoveries Act of 2022. H.R. 7053/S. 3792, Hospital Inpatient Services Modernization Act. Medicare Sequestration Moratoria. H.R. 7053/S. 3792, Hospital Inpatient Services Modernization Act.
2022 · first_quarter · Medicare/Medicaid
Coverage of blood transfusions under Medicare Hospice Benefit Improving Access to Transfusion Care for Hospice Patients Act of 2021 (S. 2566) Issues related to CAR-T/cellular and gene therapies Implementation of the Medicare Access and CHIP Reauthorization Act pf 2015 (P.L. 114-10) Implementation of the Patient Protection and Affordable Care Act (P.L. 111-148) CMS national coverage determinations Medicaid coverage for sickle cell disease Issues impacting opioid access/use for patients with hematologic disease and disorders Issues related to implementation of Coronavirus Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136) Issues related to health equity/disproportionate impact of COVID-19 on minority populations Issues related to telemedicine/telehealth COVID-19 vaccination policies/prioritization Resident Physician Shortage Reduction Act (H.R. 2256/S. 834) Healthcare Workforce Resilience Act (H.R. 2255/S. 1024) Cures 2.0 Act (H.R. 6000) Sickle cell disease/trait issues Sickle Cell Disease Comprehensive Care Act (H.R. 6216 / S.3389) Prior authorization Improving Seniors Timely Access to Care Act (H.R. 3173/S. 3018)
Client expense: $30,000 · Firm income: Not reported
2021 · fourth_quarter · Medicare/Medicaid
Medicare home health payment policy. Oppose home health and hospice payment cuts and co-pays. Home health rural add-on payment adjustment. Home Health Review Choice Demonstration Program. Hospice payment policy. CMMI VBID Medicare Advantage Carve-in proposal. Palliative Care and Hospice Education and Training Act (draft legislation). H.R. 2898/S. 1399, Homecare for Seniors Act. Medicaid payment and eligibility policy. Medicaid Money Follows the Person program. Medicaid protections against spousal impoverishments. Administration for Community Living falls prevention program. H.R. 3371/S. 1309, Home Health Emergency Access to Telehealth Act. Hospice Face to Face Telehealth recertification. Patient Choice and Quality Care Act (draft legislation). Federal response to coronavirus pandemic, including: regulatory relief, PPE, testing, telehealth, Medicaid reimbursement, and homebound status. S. 2214, PROTECTS Act. Medicaid HCBS FMAP increase. HCBS Access Act (draft legislation). Additional funding for Provider Relief Fund. COVID-19 vaccine funding, administration, and distribution to the homebound. Increased minimum wage legislative proposals. H.R. 2903/S. 1512, CONNECT for Health Act of 2021. H.R. 3321/S. 1670, Credit for Caring Act of 2021. H.R. 3689/S. 234, Americans Giving Care to Elders (AGE) Act of 2021. COVID-19 Public Health Emergency/testing of hospice patients. H.R. 2565, Expanding Access to Palliative Care Act. H.R. 5514/S. 2562, Choose Home Care Act of 2021. H.R. 5376, Build Back Better Act. H.R. 4131/S.2210, Better Care Better Jobs Act. S. 2566, Improving Access to Transfusion Care for Hospice Patients Act of 2021. Draft legislation addressing Medicare Advantage coverage at end of life. Health information technology funding and standards for long-term post-acuter care providers. COVID-19 vaccine mandate. Palliative dialysis payment policy in Medicare hospice. H.R. 4952, ChiPACC Act of 2021. H.R. 6000, Cures 2.0 Act. Long-term care health information technology modernization proposals. Allowance of distribution of personal retirement account funding for aging in place home modifications.
2021 · fourth_quarter · Medicare/Medicaid
S.3389/ H.R.6216 - Sickle Cell Disease Comprehensive Care Act Making permanent Medicare telehealth expansions allowed during Public Health Emergency Legislation to eliminate CMS planned reductions to Medicare Physician Fee Schedule Conversion Factor and other payment reductions in Medicare proposed for 2022 The Improving Access to Transfusion Care for Hospice Patients Act of 2021 (S. 2566) Need for expert panel to advise CMS on improving values for evaluation and management services National Coverage Determination on myelodysplastic syndromes (MDS)
Client expense: Not reported · Firm income: $45,000
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
2021 · fourth_quarter · Medicare/Medicaid
Coverage of blood transfusions under Medicare Hospice Benefit Improving Access to Transfusion Care for Hospice Patients Act of 2021 (S. 2566) Reimbursement for CAR-T/cellular and gene therapies Implementation of the Medicare Access and CHIP Reauthorization Act pf 2015 (P.L. 114-10) Implementation of the Patient Protection and Affordable Care Act (P.L. 111-148) CMS national coverage determinations Medicaid coverage for sickle cell disease Issues impacting opioid access/use for patients with hematologic disease and disorders Issues related to implementation of Coronavirus Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136) Issues related to health equity/disproportionate impact of COVID-19 on minority populations Issues related to telemedicine/telehealth Funding for Graduate Medical Education (GME) COVID-19 vaccination policies/prioritization Resident Physician Shortage Reduction Act (H.R. 2256/S. 834) Healthcare Workforce Resilience Act (H.R. 2255/S. 1024) Cures 2.0 Act (H.R. 6000) Sickle cell disease/trait issues Sickle Cell Disease Comprehensive Care Act (H.R. 6216 / S.3389)
Client expense: $30,000 · Firm income: Not reported
2021 · fourth_quarter · Medicare/Medicaid
Improving Access to Transfusion Care for Hospice Patients Act of 2021 (S. 2566), and supporting a CMMI demonstration project that would establish a separate payment for blood transfusions furnished to patients receiving hospice care.
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Law Enforcement/Crime/Criminal Justice
Prohibiting the Use of Acquitted Conduct Act (Senate) S. 2566 Federal Probation Reform Legislation (Unintroduced) CARES Act Implementation EQUAL Act (House and Senate) S. 79/HR 1693 Terry Technical Correction Act (Senate) S. 2914 First Step Implementation Act (Senate) S. 1014 Fresh Start Act (House and Senate) HR 5651 (Not introduced in the Senate yet)
Client expense: $10,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · third_quarter · Medicare/Medicaid
Coverage of blood transfusions under Medicare Hospice Benefit Improving Access to Transfusion Care for Hospice Patients Act of 2021 (S. 2566) Reimbursement for CAR-T/cellular and gene therapies Implementation of the Medicare Access and CHIP Reauthorization Act pf 2015 (P.L. 114-10) Implementation of the Patient Protection and Affordable Care Act (P.L. 111-148) CMS national coverage determinations Medicaid coverage for sickle cell disease Issues impacting opioid access/use for patients with hematologic disease and disorders Issues related to implementation of Coronavirus Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136) Issues related to health equity/disproportionate impact of COVID-19 on minority populations Issues related to telemedicine/telehealth Funding for Graduate Medical Education (GME) COVID-19 vaccination policies/prioritization Resident Physician Shortage Reduction Act (H.R. 2256/S. 834) Healthcare Workforce Resilience Act (H.R. 2255/S. 1024) Sickle cell disease/trait issues
Client expense: $30,000 · Firm income: Not reported
2021 · third_quarter · Medicare/Medicaid
Medicare home health payment policy. Oppose home health and hospice payment cuts and co-pays. Home health rural add-on payment adjustment. Home Health Review Choice Demonstration Program. Hospice payment policy. CMMI VBID Medicare Advantage Carve-in proposal. Palliative Care and Hospice Education and Training Act (draft legislation). H.R. 2898/S. 1399, Homecare for Seniors Act. Medicaid payment and eligibility policy. Medicaid Money Follows the Person program. Medicaid protections against spousal impoverishments. Administration for Community Living falls prevention program. H.R. 3371/S. 1309, Home Health Emergency Access to Telehealth Act. Hospice Face to Face Telehealth recertification. Patient Choice and Quality Care Act (draft legislation). Federal response to coronavirus pandemic, including: regulatory relief, PPE, testing, telehealth, Medicaid reimbursement, and homebound status. S. 2214, PROTECTS Act. Medicaid HCBS FMAP increase. HCBS Access Act (draft legislation). Additional funding for Provider Relief Fund. COVID-19 vaccine funding, administration, and distribution to the homebound. Increased minimum wage legislative proposals. H.R. 2903/S. 1512, CONNECT for Health Act of 2021. H.R. 3321/S. 1670, Credit for Caring Act of 2021. H.R. 3689/S. 234, Americans Giving Care to Elders (AGE) Act of 2021. COVID-19 Public Health Emergency/testing of hospice patients. H.R. 2565, Expanding Access to Palliative Care Act. H.R. 5514/S. 2562, Choose Home Care Act of 2021. H.R. 5376, Build Back Better Act. H.R. 4131/S.2210, Better Care Better Jobs Act. S. 2566, Improving Access to Transfusion Care for Hospice Patients Act of 2021. Draft legislation addressing MA coverage at end of life. Health information technology funding and standards for long-term post-acuter care providers. COVID-19 vaccine mandate.
2021 · third_quarter · Medicare/Medicaid
Sickle Cell Disease Medicaid Demonstration Program draft legislation Making permanent Medicare telehealth expansions allowed during Public Health Emergency The Improving Access to Transfusion Care for Hospice Patients Act of 2021 (S. 2566) Need for expert panel to advise CMS on improving values for evaluation and management services National Coverage Determination on myelodysplastic syndromes (MDS)
Client expense: Not reported · Firm income: $45,000
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
2021 · third_quarter · Medicare/Medicaid
Improving Access to Transfusion Care for Hospice Patients Act of 2021 (S. 2566), and supporting a CMMI demonstration project that would establish a separate payment for blood transfusions furnished to patients receiving hospice care. Supporting a bill that would authorize the Centers for Medicare and Medicaid Services (CMS) to develop a program for Medicaid beneficiaries to improve access to comprehensive outpatient care for individuals with sickle cell disease.
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Client expense: $220,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Client expense: $210,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Client expense: $220,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), President of the U.S., SENATE
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), President of the U.S., SENATE
Client expense: $190,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE